Contact:
Tel: +32(0) 10 39 41 00
Fax: +32(0) 10 39 41 41
Email: info@celyad.com
(C) 2023 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 EUR | 0.00% | -9.09% | -28.21% |
04-04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
Contact:
Tel: +32(0) 10 39 41 00
Fax: +32(0) 10 39 41 41
Email: info@celyad.com
(C) 2023 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-28.21% | 12.43M | |
+19.41% | 45.51B | |
+38.65% | 38.13B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |